Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Immix Biopharma, Inc.IMMX · Entity 4958 | Scientific Co-Founder | December 20, 2021 | December 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Immix Biopharma, Inc.
Report date December 20, 2021 · Filed December 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 905,200 |
Ending reported balance
After 2021-12-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-12-17 · Purchase · Acquired 2,200 · Balance 902,200 Row 2 · 2021-12-20 · Purchase · Acquired 3,000 · Balance 905,200 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2021 Filed Dec 20, 2021 21:15 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 3,000 | $5.00 | $15,000.00 |
DisclosureSEC source: 0001493152-21-032036 · ownership.xml · nonDerivative · entry 2 Torchilin Vladimir P · CIK 0001889563 · Scientific Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 905,200 Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 21:15 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 2,200 | $4.47 | $9,834.00 |
DisclosureSEC source: 0001493152-21-032036 · ownership.xml · nonDerivative · entry 1 Torchilin Vladimir P · CIK 0001889563 · Scientific Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,200 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.